federal_register: 99-14751

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
99-14751 Draft Guidance for Industry on in Vivo Pharmacokinetics and Bioavailability Studies and in Vitro Dissolution Testing for Levothyroxine Sodium Tablets; Availability Notice The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``In Vivo Pharmacokinetics and Bioavailability Studies and in Vitro Dissolution Testing for Levothyroxine Sodium Tablets.'' The draft guidance contains agency recommendations on how to design in vivo pharmacokinetics and bioavailability studies and perform in vitro dissolution testing for levothyroxine sodium tablets. DATES: Written comments on the draft guidance may be submitted by August 9, 1999. General comments on documents are welcome at any time. 1999-06-10 1999 6 https://www.federalregister.gov/documents/1999/06/10/99-14751/draft-guidance-for-industry-on-in-vivo-pharmacokinetics-and-bioavailability-studies-and-in-vitro https://www.govinfo.gov/content/pkg/FR-1999-06-10/pdf/99-14751.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled ``In Vivo Pharmacokinetics and Bioavailability Studies and in Vitro Dissolution Testing for Levothyroxine Sodium Tablets.'' The draft...

Links from other tables